Clinical trial
Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants
NCT00228319 · Jeanne Drisko, MD, CNS, FACN, Other · Completed
Key facts
| NCT number | NCT00228319 |
|---|---|
| Title | Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants |
| Official title | Antioxidant Effects on the Outcome of Ovarian Cancer |
| Lead sponsor | Jeanne Drisko, MD, CNS, FACN, Other |
| Collaborators | Cancer Treatment Research Foundation University of Kansas Medical Center |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Dietary Supplement, Drug |
| Interventions | Oral Ascorbic Acid, Paclitaxel, Carboplatin, Sodium Ascorbate, Oral Mixed natural Carotenoids with Vitamin A, Vitamin E |
| Enrollment | 27 |
| Start date | Oct 1, 2002 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Sep 28, 2005 |
| Last update posted | Jun 19, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: